Evidence map›Paper›PMID 34699518›Full record

ReviewThe American journal of case reports2021

Anorectal Mucosal Melanoma: A Case Report and Literature Review.

José Donizeti de Meira Júnior, Lucas Faraco Sobrado, Vivian M Guzela, Sergio Carlos Nahas, Carlos Walter Sobrado

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in The American journal of case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Challenges in managing anorectal melanoma, a rare malignancy.International journal of surgery case reports · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

José Donizeti de Meira JúniorColorectal Surgery Division, Department of Gastroenterology, Clinical Hospital, University of São Paulo - School of Medicine, São Paulo, SP, Brazil.
Lucas Faraco SobradoColorectal Surgery Division, Department of Gastroenterology, Clinical Hospital, University of São Paulo - School of Medicine, São Paulo, SP, Brazil.
Vivian M GuzelaColorectal Surgery Division, Department of Gastroenterology, Clinical Hospital, University of São Paulo - School of Medicine, São Paulo, SP, Brazil.
Sergio Carlos NahasColorectal Surgery Division, Department of Gastroenterology, Clinical Hospital, University of São Paulo - School of Medicine, São Paulo, SP, Brazil.
Carlos Walter SobradoColorectal Surgery Division, Department of Gastroenterology, Clinical Hospital, University of São Paulo - School of Medicine, São Paulo, SP, Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Anorectal mucosal melanoma (AMM) is a rare and aggressive neoplasm, with a 5-year survival rate of 10%. Due to its rarity and nonspecific symptoms, the diagnosis is often made late. Surgical resection remains the criterion standard for treatment of anorectal melanoma. CASE REPORT We present the case of an 81-year-old woman presenting with hematochezia, anal secretion, tenesmus, difficulty in defecation, and perianal pain. On physical examination, there was a prolapse of a 5-cm melanocytic nodule in the anal canal, hard on palpation. Biopsy confirmed anorectal melanoma. Staging revealed anal and metastatic disease, with adrenal, lymphatic, and hepatic involvement. As the patient continued to have bleeding, severe pain, and difficulty in defecation, she was submitted to a wide local excision. At 5-month follow-up, the anal lesion had relapsed, and the patient died 10 months after the procedure. CONCLUSIONS AMM is a rare and extremely aggressive tumor. Symptoms are nonspecific but early diagnosis should be pursued to allow curative treatment. Surgical resection with free margins is the goal of surgical treatment. New therapies are being studied, including immunotherapy, which can improve the dismal prognosis of this rare disease.

Indexed as

Anus NeoplasmsMelanomaRectal NeoplasmsAged, 80 and overAnal CanalFemaleHumansNeoplasm StagingRectum

Identifiers

PMID34699518
PMCPMC8557858
OpenAlexW3203595886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.